Little Green Pharma owns and operates two medicinal cannabis cultivation and production facilities, located in Western Australia and Denmark, Europe. These sites support supply to regulated markets in Australia and internationally, operating under recognised manufacturing and compliance frameworks.
Australian Facility
The Australian facility, based in the South West of Western Australia, is an indoor cultivation site with the capacity to produce over two tonnes of biomass each year. Designed for controlled environment growing, the site also includes infrastructure for the ongoing development of plant genetics and supports the expansion of the company’s flower portfolio. The facility is aligned with post-harvest practices consistent with Good Manufacturing Practice (GMP) standards.
Denmark Facility
The Denmark facility is one of the largest production sites in the Europe region. Acquired by Little Green Pharma in 2021, the site has a production capacity of more than 30 tonnes of biomass per annum. The facility is designed to respond to changes in demand across both the Australian and European markets. It also supports a genetics development program, with over 20 production strains currently in progress.
Supporting Regulated Markets
These two facilities are central to Little Green Pharma’s cultivation and production operations and contribute to the company’s ability to service multiple regulated markets. By combining science, nature, and compassion, we aim to raise awareness and understanding of medicinal cannabis in a responsible way.
Contact Us For Free Assistance
"*" indicates required fields